AstraZeneca Aiming to Transform Landscape of Oncology Treatment
AstraZeneca is going to be presenting the new data that is highlighting the breadth of the early oncology portfolio of the company at the annual meeting of AACR (American Association for cancer Research) in the region of New Orleans from 8to 13 April 2022. The data from the 60 presentations including 3 mini-oral and 5 […]
Continue Reading